Steven W. Spector

2012

In 2012, Steven W. Spector earned a total compensation of $2.2M as Executive Vice President, General Counsel and Secretary at Arena Pharmaceuticals, a 171% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$225,000
Option Awards$1,289,200
Salary$375,000
Stock Awards$266,100
Other$86,399
Total$2,241,699

Spector received $1.3M in option awards, accounting for 58% of the total pay in 2012.

Spector also received $225K in non-equity incentive plan, $375K in salary, $266.1K in stock awards and $86.4K in other compensation.

Rankings

In 2012, Steven W. Spector's compensation ranked 3,165th out of 11,487 executives tracked by ExecPay. In other words, Spector earned more than 72.4% of executives.

ClassificationRankingPercentile
All
3,165
out of 11,487
72nd
Division
Manufacturing
1,101
out of 4,253
74th
Major group
Chemicals And Allied Products
247
out of 1,203
80th
Industry group
Drugs
145
out of 925
84th
Industry
Pharmaceutical Preparations
117
out of 700
83rd
Source: SEC filing on April 29, 2015.

Spector's colleagues

We found four more compensation records of executives who worked with Steven W. Spector at Arena Pharmaceuticals in 2012.

2012

Jack Lief

Arena Pharmaceuticals

Chief Executive Officer

2012

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2012

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

2012

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

In-depth

You may also like